Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

BACKGROUND: GP88/Progranulin is a well-recognized cell growth promoter in different cancers, and elevated serum GP88 levels have been described as negative prognostic factor in breast cancer. However, serum levels in prostate cancer (PCa) patients have not yet been studied. MATERIAL AND METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Greither, Thomas, Fischer, Kersten, Theil, Gerit, Marcou, Marios, Holzhausen, Hans-Juergen, Weigelt, Katrin, Serrero, Ginette, Hicks, David, Yue, Binbin, Fornara, Paolo, Wullich, Bernd, Taubert, Helge, Wach, Sven, Lieb, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178934/
https://www.ncbi.nlm.nih.gov/pubmed/30323673
http://dx.doi.org/10.2147/CMAR.S172069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178934/
https://www.ncbi.nlm.nih.gov/pubmed/30323673
http://dx.doi.org/10.2147/CMAR.S172069

Ejemplares similares